These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 1844328

  • 1. The use of GnRH agonists depot for the treatment of dysfunctional uterine bleeding.
    Colacurci N, De Placido G, Galasso M, Mollo A, Perino A, Cittadini E.
    Acta Eur Fertil; 1991; 22(4):229-31. PubMed ID: 1844328
    [Abstract] [Full Text] [Related]

  • 2. [Hysteroscopic ablation of the endometrium in cases of dysfunctional uterine bleeding--advantage of preparations including zoladex].
    Tiufekchieva E, Nikolov A.
    Akush Ginekol (Sofiia); 2002; 41(2):30-4. PubMed ID: 12066549
    [Abstract] [Full Text] [Related]

  • 3. Diagnosis of endometrial hyperplasia in women with abnormal uterine bleeding.
    Loverro G, Bettocchi S, Vicino M, Selvaggi L.
    Acta Eur Fertil; 1994; 25(1):23-5. PubMed ID: 7887077
    [Abstract] [Full Text] [Related]

  • 4. [Treatment of endometrial hyperplasia with Goserelin depot, an LH-RH analog].
    Pozzi M, Castagnola D, Cherubini F.
    Minerva Ginecol; 1993 May; 45(5):251-4. PubMed ID: 8351064
    [Abstract] [Full Text] [Related]

  • 5. Depot goserelin and danazol pre-treatment before rollerball endometrial ablation for menorrhagia.
    Fraser IS, Healy DL, Torode H, Song JY, Mamers P, Wilde F.
    Obstet Gynecol; 1996 Apr; 87(4):544-50. PubMed ID: 8602306
    [Abstract] [Full Text] [Related]

  • 6. [The use of GnRH agonists in severe uterine hemorrhages in adolescence caused by congenital aplastic and hypoplastic anemias].
    Nikolov A, Bŭrdarova I, Kolarov G, Veltova L.
    Akush Ginekol (Sofiia); 1999 Apr; 38(2):46-8. PubMed ID: 10730389
    [Abstract] [Full Text] [Related]

  • 7. Endometrial carcinoma after endometrial resection for dysfunctional uterine bleeding.
    Sagiv R, Ben-Shem E, Condrea A, Glezerman M, Golan A.
    Obstet Gynecol; 2005 Nov; 106(5 Pt 2):1174-6. PubMed ID: 16260560
    [Abstract] [Full Text] [Related]

  • 8. [The role of hysteroscopy in the diagnosis and follow-up of endometrial hyperplasia].
    Gubbini G, Filoni M, Linsalata I, Stagnozzi R, Stefanetti M, Marabini A.
    Minerva Ginecol; 1998 Apr; 50(4):125-33. PubMed ID: 9691636
    [Abstract] [Full Text] [Related]

  • 9. Goserelin acetate (Zoladex) plus endometrial ablation for dysfunctional uterine bleeding: a large randomized, double-blind study.
    Donnez J, Vilos G, Gannon MJ, Stampe-Sorensen S, Klinte I, Miller RM.
    Fertil Steril; 1997 Jul; 68(1):29-36. PubMed ID: 9207580
    [Abstract] [Full Text] [Related]

  • 10. Goserelin treatment in glandular hyperplasia.
    Garozzo G, La Greca M, Lomeo E, Panella M.
    Clin Exp Obstet Gynecol; 1993 Jul; 20(4):268-72. PubMed ID: 8281712
    [Abstract] [Full Text] [Related]

  • 11. Hysteroscopy with selective endometrial sampling compared with D&C for abnormal uterine bleeding: the value of a negative hysteroscopic view.
    Loffer FD.
    Obstet Gynecol; 1989 Jan; 73(1):16-20. PubMed ID: 2909040
    [Abstract] [Full Text] [Related]

  • 12. [Study on women with abnormal uterine bleeding treated by hysteroscopic electric resection].
    Zhang X, Lin J, Xu K.
    Zhonghua Fu Chan Ke Za Zhi; 2000 Dec; 35(12):727-9. PubMed ID: 11286031
    [Abstract] [Full Text] [Related]

  • 13. Hysteroscopic evaluation of intrauterine progesterone contraceptive system as a treatment for abnormal uterine bleeding.
    Scarselli G, Mencaglia L, Tantini C, Colafranceschi M, Taddei G.
    Acta Eur Fertil; 1984 Dec; 15(4):279-82. PubMed ID: 6240880
    [Abstract] [Full Text] [Related]

  • 14. [Anomalous uterine bleeding in the perimenopause: fibromatosis, hyperplastic endometriopathy and GnRH analogs].
    Vitale G, Linciano M, Salamanca S, Ferrari P.
    Minerva Ginecol; 1994 Jun; 46(6):317-20. PubMed ID: 7936383
    [Abstract] [Full Text] [Related]

  • 15. Validation of hysteroscopic view in cases of endometrial hyperplasia and cancer in patients with abnormal uterine bleeding.
    Lasmar RB, Barrozo PR, de Oliveira MA, Coutinho ES, Dias R.
    J Minim Invasive Gynecol; 2006 Jun; 13(5):409-12. PubMed ID: 16962523
    [Abstract] [Full Text] [Related]

  • 16. Short-term use of Goserelin depot in the treatment of dysfunctional uterine bleeding.
    Colacurci N, De Placido G, Mollo A, Perino A, Cittadini E.
    Clin Exp Obstet Gynecol; 1995 Jun; 22(3):212-9. PubMed ID: 7554259
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic and therapeutic hysteroscopy in the management of abnormal uterine bleeding.
    Motashaw ND, Dave S.
    J Reprod Med; 1990 Jun; 35(6):616-20. PubMed ID: 2359060
    [Abstract] [Full Text] [Related]

  • 18. Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding.
    Crosignani PG, Vercellini P, Mosconi P, Oldani S, Cortesi I, De Giorgi O.
    Obstet Gynecol; 1997 Aug; 90(2):257-63. PubMed ID: 9241305
    [Abstract] [Full Text] [Related]

  • 19. Office hysteroscopic evaluation of endometrium: can we hit the target?
    Arslan S, Aytan H, Gunyeli I, Koc O, Tuncay G, Tapisiz OL.
    Arch Gynecol Obstet; 2005 Mar; 271(3):200-2. PubMed ID: 15316824
    [Abstract] [Full Text] [Related]

  • 20. Gonadotropin releasing hormone agonist for chronic anovulatory uterine bleeding and severe anemia.
    Vercellini P, Fedele L, Maggi R, Vendola N, Bocciolone L, Colombo A.
    J Reprod Med; 1993 Feb; 38(2):127-9. PubMed ID: 8445603
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.